FDA Approves Kalydeco (ivacaftor) for Cystic Fibrosis in Children Ages 12 to <24 Months with Certain Mutations in the CFTR Gene

BOSTON–(BUSINESS WIRE)–Aug. 15, 2018– Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) approved Kalydeco (ivacaftor) to include use in children with cystic fibrosis (CF) ages 12 to <24 months who have at least one mutation in their cystic fibrosis transmembrane conductance regulator (CFTR) gene that is responsive to Kalydeco based on clinical and/or in […]

Read more

12 Brand-Name Drugs That May Never Go Generic

A recent analysis by I-MAK reveals that drug makers have leveraged the patent system to prevent generic competition, retain monopolies on expensive drugs and raise drug prices. This research comes months after the Trump administration released the American Patients First blueprint for lowering drug prices. Among the many initiatives included in the blueprint, the administration discussed strategies for increasing access […]

Read more

Study: What patients really think about opioid vs non-opioid medications for chronic pain

Prescriptions of opioids for chronic pain has increased dramatically since the 1990s in spite of their known harms. Despite a shortage of scientific studies on the long-term effectiveness of opioids such as morphine, oxycodone and hydrocodone, they are frequently perceived to be stronger, more powerful pain relievers than non-opioid alternatives like acetaminophen or ibuprofen. A new study investigates pre-existing perceptions […]

Read more

FDA Approves Annovera

NEW YORK, Aug. 10, 2018 /PRNewswire/ — The Population Council, a global nonprofit research organization, announced it has received U.S. Food and Drug Administration (FDA) approval for Annovera™ (segesterone acetate and ethinyl estradiol vaginal system), the first and only contraceptive that provides an entire year of protection against unintended pregnancy while fully under a woman’s control. The approval marks an […]

Read more

Benzodiazepine and related drug prescriptions have increased among young people in Sweden

The prevalence rate of prescriptions for benzodiazepines and benzodiazepine-related drugs (BZD)—medications used to treat anxiety, insomnia, epilepsy and other neuropsychiatric conditions—increased by 22% between 2006 and 2013 among individuals aged 0-24 years in Sweden, according to a study published this week in PLOS Medicine. The study, conducted by Anna Sidorchuk of the Karolinska Institutet, Stockholm, and colleagues, indicates that during […]

Read more

United Therapeutics Announces FDA Approval of the Implantable System for Remodulin

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., July 31, 2018 /PRNewswire/ — United Therapeutics Corporation (NASDAQ: UTHR) today announced approval by the U.S. Food and Drug Administration (FDA) of a New Drug Application (NDA) for the use of Remodulin (treprostinil) Injection in the Implantable System for Remodulin® (ISR). The ISR has been developed under a collaboration with Medtronic (NYSE: […]

Read more

Here’s Why Your Pharmacist Won’t Fill Your Prescription — and What You Can Do About It (Part 1)

This is Part 1 in our two-part series on why pharmacists may not fill your prescription. In Part 2, we cover issues like scripts that looked altered and possible drug-drug interactions.  Here are four reasons why your pharmacist can refuse to fill your prescription: 1) The prescription is missing information. Pharmacies receive prescriptions in a couple of different ways: Prescriptions […]

Read more

Behavioral nudges lead to striking drop in prescriptions of potent antipsychotic

A study led by Columbia University’s Mailman School of Public Health has found that letters targeting high prescribers of Seroquel (quetiapine), an antipsychotic with potentially harmful side effects in the elderly, significantly reduced the number of prescriptions for patients in Medicare. The results showed that peer comparison letters led to statistically meaningful, persistent decreases in quetiapine prescribing, with no detected […]

Read more

Maryland hits record-high drug deaths, fueled by fentanyl

Maryland notched a record-high number of drug deaths last year, fueled by an alarming increase of fentanyl-related fatalities amid an escalating epidemic. Newly released figures from Maryland’s health department show there were 2,282 intoxication deaths in 2017. Nearly 90 percent of those deaths were opioid-related. The hard-hit state’s fentanyl-related deaths continue to soar, increasing from 1,119 in 2016 to an […]

Read more
1 19 20 21 22 23